Quantcast

Latest drug discovery Stories

2014-09-18 08:29:10

Drug Development Team Now Complete and Fully Focused on Clinical Trial Implementation NEW YORK, Sept. 18, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has appointed Mr. Christopher W. James to the position of Senior Director of Clinical Development. During his extensive career in Clinical Research, Mr. James has established and led successful global...

2014-09-17 23:14:27

The Freeslate Core Module 3 Reaction Screening System will be used to advance small molecule organic chemistry research objectives Sunnyvale, CA (PRWEB) September 17, 2014 Freeslate, Inc., the leading provider of high throughput research solutions for drug development, today announced that Baylor University acquired a Freeslate Core Module 3 (CM3) Reaction Screening System to both support Baylor research interests and provide screening services to the Texas community. Freeslate’s high...

2014-09-17 16:27:36

RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2014 /PRNewswire/ -- The In Silico Drug Discovery Conference today announced speakers and presentation topics that will be featured at the conference, which takes place at North Carolina Biotechnology Center's Hamner Conference Center on December 3 and 4, 2014. Researchers, students, drug developers, business development professionals, and biotechnology managers are invited to hear the following: KEYNOTE SPEAKERS Ruben Abagyan, PhD UC San Diego Skaggs...

2014-09-17 12:27:05

New multi-year grant furthers non-profit organization's work to accelerate the drug development process TUCSON, Ariz., Sept. 17, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute (C-Path) announced today that the U.S. Food and Drug Administration (FDA) has awarded the organization $2.1 million in first year funding of a five-year grant with the potential of $10.5 million over the five years. This is the second five-year grant that C-Path has received from the FDA under the...

2014-09-16 23:11:40

Achieve Clinical Research is looking for adults who have never have not been vaccinated for pneumonia within the last year to take part in this new clinical study. Applicants should be at least 18 years old in order to qualify for a clinical trial here in Birmingham. Birmingham, Alabama (PRWEB) September 16, 2014 *To find out more about this pneumonia vaccine clinical trial in Birmingham, AL, visit Achieve Clinical Research on the web...

2014-09-16 12:30:26

BOSTON, September 16, 2014 /PRNewswire/ -- Russia's pharmaceutical market has been growing faster over recent years. The Pharma 2020 Strategy provides incentives for local producers to develop original and generic drugs for both domestic and foreign markets. These trends, however, were affected by recent developments connected with the political situation and the following political and economic sanctions imposed on Russia. (Logo:...

2014-09-16 04:21:23

LONDON and BOSTON, September 16, 2014 /PRNewswire/ -- Heptares Therapeutics notes that its Chief Scientific Officer, Fiona Marshall, will give a presentation entitled "Structure-based Drug Design for G protein-coupled receptors using StaR(R) technology" as part of the inaugural "Advances in Drug Discovery and Development" virtual symposium run by Chemical & Engineering News, a publication of the American Chemical Society. The virtual symposium is on Wednesday, 24 September...

2014-09-15 08:29:50

SPRINGFIELD, N.J., Sept. 15, 2014 /PRNewswire/ -- Hudson Robotics, Inc., of Springfield, NJ, in cooperation with Johns Hopkins University, has recently been awarded an NIH grant to develop a commercially viable high-throughput screening (HTS) system for in vivo studies of zebrafish. Logo - http://photos.prnewswire.com/prnh/20140912/145910 This system, termed the Automated Reporter Quantification in vivo (ARQiv) system, will bring high-throughput screening technology into the realm...

2014-09-12 08:25:44

SARASOTA, Fla., Sept. 12, 2014 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic disorders, announced today it has received a written response from the U.S. Food and Drug Administration (FDA) in response to the New Dietary Ingredient Notification (NDIN) for the formulations of Anatabloc® and CigRx® submitted by the Company in June 2014. The letter indicated that the FDA considers...

2014-09-10 12:27:57

NEW YORK, Sept. 10, 2014 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) and OnDeckBiotech announced today the launch of ADDF ACCESS, a new and improved open access platform to connect scientists with a virtual network of contract research organizations (CROs), drug development experts and educational resources. By leveraging OnDeckBiotech's cutting-edge technology, the enhanced ADDF ACCESS platform will streamline links between researchers and CROs specializing...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'